JP2009539875A5 - - Google Patents

Download PDF

Info

Publication number
JP2009539875A5
JP2009539875A5 JP2009514544A JP2009514544A JP2009539875A5 JP 2009539875 A5 JP2009539875 A5 JP 2009539875A5 JP 2009514544 A JP2009514544 A JP 2009514544A JP 2009514544 A JP2009514544 A JP 2009514544A JP 2009539875 A5 JP2009539875 A5 JP 2009539875A5
Authority
JP
Japan
Prior art keywords
phenyl
chloro
methoxy
thieno
hydrochloride
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009514544A
Other languages
English (en)
Japanese (ja)
Other versions
JP5198439B2 (ja
JP2009539875A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/070662 external-priority patent/WO2007146758A2/en
Publication of JP2009539875A publication Critical patent/JP2009539875A/ja
Publication of JP2009539875A5 publication Critical patent/JP2009539875A5/ja
Application granted granted Critical
Publication of JP5198439B2 publication Critical patent/JP5198439B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009514544A 2006-06-08 2007-06-08 新規なmch受容体アンタゴニスト Expired - Fee Related JP5198439B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US81184106P 2006-06-08 2006-06-08
US60/811,841 2006-06-08
PCT/US2007/070662 WO2007146758A2 (en) 2006-06-08 2007-06-08 Novel mch receptor antagonists

Publications (3)

Publication Number Publication Date
JP2009539875A JP2009539875A (ja) 2009-11-19
JP2009539875A5 true JP2009539875A5 (https=) 2010-07-22
JP5198439B2 JP5198439B2 (ja) 2013-05-15

Family

ID=38651254

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009514544A Expired - Fee Related JP5198439B2 (ja) 2006-06-08 2007-06-08 新規なmch受容体アンタゴニスト

Country Status (10)

Country Link
US (2) US8263772B2 (https=)
EP (1) EP2029609A2 (https=)
JP (1) JP5198439B2 (https=)
CN (1) CN101454328A (https=)
AU (1) AU2007257922A1 (https=)
BR (1) BRPI0712680A2 (https=)
CA (1) CA2652385A1 (https=)
EA (1) EA015127B1 (https=)
MX (1) MX2008015662A (https=)
WO (1) WO2007146758A2 (https=)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2740193A1 (en) 2008-12-23 2010-07-01 Abbott Laboratories Anti-viral compounds
EP2367823A1 (en) 2008-12-23 2011-09-28 Abbott Laboratories Anti-viral compounds
BRPI0923527A2 (pt) * 2008-12-24 2016-08-09 Syngenta Ltd métodos de preparo de fungicidas
CN102459165B (zh) * 2009-04-15 2015-09-02 Abbvie公司 抗病毒化合物
US8937150B2 (en) 2009-06-11 2015-01-20 Abbvie Inc. Anti-viral compounds
US9394279B2 (en) 2009-06-11 2016-07-19 Abbvie Inc. Anti-viral compounds
UA118080C2 (uk) 2009-06-11 2018-11-26 Еббві Айрленд Анлімітед Компані Противірусні сполуки
US8716454B2 (en) 2009-06-11 2014-05-06 Abbvie Inc. Solid compositions
NZ605440A (en) 2010-06-10 2014-05-30 Abbvie Bahamas Ltd Solid compositions comprising an hcv inhibitor
US10201584B1 (en) 2011-05-17 2019-02-12 Abbvie Inc. Compositions and methods for treating HCV
US9034832B2 (en) 2011-12-29 2015-05-19 Abbvie Inc. Solid compositions
US20150065343A1 (en) 2012-04-02 2015-03-05 Basf Se Acrylamide compounds for combating invertebrate pests
BR112014027133A2 (pt) 2012-05-09 2017-06-27 Basf Se compostos, composição agrícola ou veterinária, método para o controle das pragas de invertebrados, material de propagação dos vegetais e método para o tratamento ou proteção de um animal.
MX394360B (es) 2013-03-14 2025-03-24 Sumitomo Pharma Oncology Inc Inhibidores de jak2 y alk2 y metodos para su uso.
US11484534B2 (en) 2013-03-14 2022-11-01 Abbvie Inc. Methods for treating HCV
EP3089757A1 (en) 2014-01-03 2016-11-09 AbbVie Inc. Solid antiviral dosage forms
AR102849A1 (es) * 2015-03-09 2017-03-29 Astellas Pharma Inc Compuesto de piridina bicíclica
ES2849951T3 (es) 2015-06-18 2021-08-24 89Bio Ltd Derivados de piperidina 4-bencil y 4-benzoil sustituidos
EA201890086A1 (ru) 2015-06-18 2018-06-29 Сефалон, Инк. 1,4-замещенные производные пиперидина
MX2021000977A (es) 2018-07-26 2021-04-12 Sumitomo Pharma Oncology Inc Metodos para tratar enfermedades asociadas con expresion anormal de receptor de activina a tipo 1 (acvr1) e inhibidores de acvr1 para uso en los mismos.
CN113226322A (zh) 2018-10-30 2021-08-06 诺维逊生物股份有限公司 作为bet抑制剂的杂环化合物
EP3997070A4 (en) 2019-07-02 2023-07-26 Nuvation Bio Inc. HETEROCYCLIC COMPOUNDS AS BET INHIBITORS
US20260028336A1 (en) * 2022-07-20 2026-01-29 Arcus Biosciences, Inc. Cbl-b inhibitors and methods of use thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002003370A (ja) * 1999-09-20 2002-01-09 Takeda Chem Ind Ltd メラニン凝集ホルモン拮抗剤
US20020099073A1 (en) * 2000-07-07 2002-07-25 Andersen Henrik Sune Modulators of protein tyrosine phosphatases (PTPases)
GB0124627D0 (en) * 2001-10-15 2001-12-05 Smithkline Beecham Plc Novel compounds
US20060194871A1 (en) * 2003-04-11 2006-08-31 Barvian Kevin K Heterocyclic mchr1 antagoists
US20070078125A1 (en) * 2003-10-23 2007-04-05 Glaxo Group Limited Arylamine mch r1 antagonists
WO2005047293A1 (en) * 2003-11-07 2005-05-26 Neurocrine Biosciences, Inc. Melanin-concentrating hormone receptor antagonists and compositions and methods related thereto
UA83416C2 (en) * 2004-02-13 2008-07-10 Баниу Фармасьютикал Ко., Лтд. Fused ring 4-oxopyrimidine derivative
US20050256124A1 (en) * 2004-04-15 2005-11-17 Neurocrine Biosciences, Inc. Melanin-concentrating hormone receptor antagonists and compositions and methods related thereto
MXPA06014535A (es) 2004-06-18 2007-06-05 Biolipox Ab Indoles utiles en el tratamiento de la inflamacion.
US7902356B2 (en) * 2004-12-17 2011-03-08 Eli Lilly And Company Thiazolopyridinone derivates as MCH receptor antagonists
EP1987020B1 (en) * 2006-02-15 2012-10-03 Sanofi Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
KR20080094699A (ko) * 2006-02-15 2008-10-23 사노피-아벤티스 신규 아미노알콜-치환된 아릴디하이드로이소퀴놀리논, 이의제조 방법 및 이의 약물로서의 용도

Similar Documents

Publication Publication Date Title
JP2009539875A5 (https=)
US11485745B2 (en) Amido spirocyclic amide and sulfonamide derivatives
ES2985528T3 (es) Nuevos compuestos y composiciones farmacéuticas de los mismos para el tratamiento de enfermedades
FI3932919T3 (fi) Jak-inhibiittoriyhdiste ja sen käyttö
ES2441017T3 (es) Compuesto de pirazolo[1,5-A]pirimidina como antagonista del receptor CB1
ES2993440T3 (en) Heterocyclic derivatives and use thereof
US12606554B2 (en) Compounds and pharmaceutical compositions thereof for the treatment of diseases
JP2013523889A5 (https=)
PT1539753E (pt) Compostos de pirazolo(3,4-b)piridina e sua utilização como inibidores da fosfodiesterase
JP2004520324A5 (https=)
CA2650290A1 (en) Pharmaceutical compounds
WO2000047558A1 (en) Amide compounds and medicinal use thereof
NZ553886A (en) Piperidinylamino-thieno[2,3-D] pyrimidine compounds
JP2013539789A5 (https=)
JP7597709B2 (ja) 置換インドールおよびインダゾール化合物
RU2612251C2 (ru) Соединения диоксин- и оксазин[2,3-d]пиримидина в качестве ингибиторов фосфоинозитид-3-киназы и способы их применения
HRP20160725T1 (hr) Biciklični heterociklični derivati kao inhibitori fgfr kinaze za primjenu u terapiji
EP2820018A1 (en) Amido-benzyl sulfone and sulfoxide derivatives
JP2015524450A5 (https=)
IL305843B2 (en) CSF-1R receptor antibodies
JP2010532387A5 (https=)
JP2017531672A5 (https=)
JP2008517913A5 (https=)
RU2014131367A (ru) Соединения тиенопиримидина
JP2018525377A5 (https=)